We’re pleased to announce that Harry Marquis’s abstract to the 2020 Annual Meeting of the SNMMI was awarded the Arthur M. Weis prize. Harry’s abstract followed from a collaboration initiated during a CCP PETMR-funded exchange. See also https://sydneyvital.org.au/congratulations-harry-marquis-2020-arthur-m-weis-phd-award/.

SPECT/CT-based Dosimetry in PRRT: Using Theranostics to Minimise the Impact of the Partial Volume Effect,

Harry Marquis,¹ , Daniel Deidda,² , Ashley Gillman,³ , Yaser Gholami,⁴ , Kathy P. Willowson,⁵, Kris F. Thielemans, ⁶, Dale L. Bailey,⁵.

1. School of Physics, University of Sydney, Sydney, Australia,
2. National Physical Laboratory, Teddington, United Kingdom,
3. Australian e-Health Research Centre, CSIRO, Brisbane, Australia,
4. Sydney Vital Translational Cancer Research Centre, Sydney, Australia,
5. Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, Australia,
6. University College London, London, United Kingdom.

Arthur M. Weis award information:

This award celebrates the considerable contributions of Art Weis to the field of nuclear medicine. As founder and chief executive of Capintec, Inc., Art championed technological advances in the accurate assessment of administered activity and biological assays of radioactivity at a time when these considerations, of fundamental importance to our field, were not as refined as they are now. In addition, Art was very active within the SNMMI, serving as chair of a number of essential committees and receiving the SNM Presidential Distinguished Service Award in 2008. The Art Weis Award recognizes outstanding original work in radiation safety and dosimetry, as Art considered these to be crucial to the advancement of nuclear medicine. Abstracts submitted by physicians, scientists or technologists which advance these concepts are hereby solicited for consideration for this award.